Benjannet S, Lusson J, Hamelin J, Savaria D, Chrétien M, Seidah N G
J. A. De Sève Laboratory of Molecular Neuroendocrinology, Clinical Research Institute of Montreal, Canada.
FEBS Lett. 1995 Apr 3;362(2):151-5. doi: 10.1016/0014-5793(95)00228-2.
Site directed mutagenesis of the prohormone convertase PC2 was used to define the effect of certain residues on the zymogen activation of proPC2 and on its binding to the neuroendocrine protein 7B2. These included the oxyanion hole Asp309 (D309N), the N-terminal Glu25 (E25Q and E25K) of proPC2 and the Asp519 (D519E) of the RGD motif within the P-domain of PC2. Heterologous vaccinia virus expression of the wild type and mutant PC2's in endocrine pituitary cells such as AtT20 and GH3 cells demonstrated that the most dramatic effect was observed with the D309N mutant which no longer bound pro7B2 and which exhibited a significant reduction in its capacity to produce beta-endorphin from pro-opiomelanocortin (POMC).
